The economic impact of GERD and PUD: Examination of direct and indirect costs using a large integrated employer claims database

Current Medical Research and Opinion

Volumn 21, Issue 4, 2005, Pages 535-543

  Joish, Vijay N ^a   Donaldson, Gary ^a   Stockdale, William ^a   Oderda, Gary M ^a   Crawley, Joseph ^b   Sasane, Rahul ^b   Joshua Gotlib, Sandra ^b   Brixner, Diana I ^a  

^a UNIVERSITY OF UTAH   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Absenteeism; Gastroesophageal reflux disease; Peptic ulcer disease; Productivity; Work loss

Indexed keywords

ABSENTEEISM; ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISABILITY; ECONOMIC EVALUATION; EMPLOYEE; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATION; OUTPATIENT CARE; PEPTIC ULCER; PRESCRIPTION;

ABSENTEEISM; ADULT; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; OCCUPATIONS; PEPTIC ULCER; RETROSPECTIVE STUDIES; UNITED STATES; WORKERS' COMPENSATION; WORKPLACE;

EID: 18744414815     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X38240     Document Type: Conference Paper

References (24)

1. National Institutes of Health. NIH Publication No. 94-882, September 1994; updated April 2000
2. Sandler R, Everhart J, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterol 2002;122:1500-11
3. Frank L, Kleinman L, Ganoczy D, et al. Upper gastrointestinal symptoms in North America: prevalence and relationship to health care utilization and quality of life. Dig Dis Sci 2000;45:809-18
4. Sonnenberg A, Everhart JE. The prevalence of self-reported peptic ulcer in the United States. Am J Public Health 1996;86:200-5
5. Everhart JE, Byrd-Holt D, Sonnenberg A. Incidence and risk factors for self-reported peptic ulcer disease in the United States. Am J Epidemiol 1998;147:529-36
6. Dean BB, Crawley JA, Schmitt CM, et al. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther 2003;17:1309-17
7. Sonnenberg A, Everhart JE. Health impact of peptic ulcer in the United States. Am J Gastroenterol 1997;92:614-20
8. Levin TR, Schmittdiel JA, Kunz K, Henning JM, Henke CJ, Colby CJ, Selby JV. Costs of acid-related disorders to a health maintenance organization. Am J Med 1997;103:520-8
9. Henke C, Levin T, Henning J, et al. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health management organization. Am J Gastroenterol 2000;95:788-92
10. Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 2002;20:347-55
11. Berndt ER, Bir A, Busch SH, Frank RG, Normand SL. The medical treatment of depression, 1991-1996: productive inefficiency, expected outcome variations, and price indexes. J Health Econ 2002;21:373-96
12. Goetzel RZ, Ozminkowski RJ, Meneades L, Stewart M, Schutt DC. Pharmaceuticals-cost or investment? An employer's perspective. J Occup Environ Med 2000;42:338-51
13. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999;159:813-8
14. Holzer SS, Juday TR, Joelsson B, Crawley JA. Determining the cost of gastroesophageal reflux disease: a decision analytic model. Am J Manag Care 1998;4:1450-60
15. Joish VN, Sahai A. Evaluating the role of confounding in pharmacoeconomic studies. Manag Care Interface 2003;16:31-5
16. Iezzoni LI. Risk adjustment for measuring health care outcomes, 2nd edn, 1999, Chicago: Health Administration Press
17. Stockdale WA, Brixner DI. Comorbidity influence index. Value in Health 2004;7:232
18. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27
19. U.S. Department of Labor, Bureau of Labor Statistics. Available from: http://data.bls.gov [Accessed 5 August 2003]
20. Graham DY, Rakel RE, Fenderick AM, Go MF, Marshall BJ, Peura DA, Scherger JE. Scope and consequences of peptic ulcer disease: How important is asymptomatic Helicobacter pylori infection? Postgrad Med 1999;105:100-12
21. Cohen J. Statistical power analysis for the behavioral sciences, 2nd edn, 1988. Hillsdale: Lawrence Erlbaum Associates
22. Goetzel RZ, Guindon AM, Turshen IJ, et al. Health and productivity management - establishing key performance measures, benchmarks and best prices. J Occup Env Med 2001;43:10-7
23. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-12
24. Sonnenberg A, Schwartz JS, Cutler AF, et al. Cost savings in duodenal ulcer therapy through H. pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointerstinal utilization Trial Study Group. Arch Intern Med 1998;158:852-60